Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Epoprostenol 1.5mg (pH10.5) inf vials
0208010E0AAABAB
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 1.5mg pdr & solv inf vials
0208010E0AAAEAE
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 1.5mg pdr for soln (pH12) inf vials
0208010E0AAADAD
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 500microgram (pH10.5) inf vials
0208010E0AAAAAA
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 500microgram pdr & solv inf vials
0208010E0AAAFAF
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 500microgram pdr for soln (pH12) inf vials
0208010E0AAACAC
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.